HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers (Q39479003)

12 September 2017

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers (English)

1 reference

12 September 2017

0 references

0 references

0 references

P Sonnenberg

1

0 references

author name string

J Murray

2

1 reference

12 September 2017

J R Glynn

3

1 reference

12 September 2017

S Shearer

4

1 reference

12 September 2017

B Kambashi

5

1 reference

12 September 2017

P Godfrey-Faussett

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

12 September 2017

1 reference

12 September 2017

358

1 reference

12 September 2017

1687-1693

1 reference

12 September 2017

9294

1 reference

Exogenous reinfection in tuberculosis

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Recurrent tuberculosis due to exogenous reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Molecular Epidemiology of Tuberculosis among HIV-Infected Persons in Switzerland: A Countrywide 9-Year Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Relapse and mortality among HIV-infected and uninfected patients with tuberculosis successfully treated with twice weekly directly observed therapy in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Tuberculosis control and molecular epidemiology in a South African gold-mining community

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906712-5

7 January 2021

10.1016/S0140-6736(01)06712-5

Identifiers

DOI

1 reference

12 September 2017

1 reference